UnitedHealth’s fourth quarter results were met with a significant negative market reaction, as management highlighted ongoing challenges in its Medicare Advantage and Medicaid businesses. CEO Stephen Hemsley described 2025 as a year of “critical self-examination,” emphasizing actions to rightsize membership, reprioritize margin over volume, and address operational inconsistencies—particularly within OptumHealth. Both Hemsley and UnitedHealthcare CEO Timothy Noel pointed to elevated medical cost trends and competitive pressures in Medicare Advantage as key drivers of membership losses and compressed operating margins. Management acknowledged that recent restructuring actions, including divesting non-core assets and workforce reductions, were necessary to establish a stronger foundation for future performance.
Healthcare distributor and services company McKesson (NYSE:MCK)
will be announcing earnings results this Wednesday after the bell. Here’s what to expect.
In a move that caught Wall Street's aggressive easing bulls off guard, the Federal Reserve maintained its benchmark interest rate at 3.5% to 3.75% during its January 2026 meeting, signaling a stark departure from the rapid-fire cuts seen in late 2025. Federal Reserve Chair Jerome Powell, in one
Ten large-cap stocks posted steep weekly losses, driven by analyst downgrades, leadership headlines, and sector pressure across healthcare, tech, and precious metals.
In a historic display of market resilience and technological optimism, the S&P 500 index officially crossed the 7,000-point threshold on January 28, 2026. This monumental achievement marks a new era for Wall Street, coming just fourteen months after the index first touched 6,000 in late 2024. The
In 2026, five comeback stocks are expected to rise with Novo Nordisk leading the pack after receiving FDA approval for its oral GLP-1 treatment and UnitedHealth Group negotiating with the Trump administration for favorable Medicare rates.
The Federal Reserve concluded its first policy meeting of the year on January 28, 2026, electing to maintain the federal funds rate at its current target range of 3.50% to 3.75%. This decision marks a "strategic pause" in the central bank's easing cycle, following three consecutive rate reductions
In a move that signaled a shift from aggressive easing to a strategic "wait-and-see" approach, the Federal Open Market Committee (FOMC) concluded its two-day policy meeting on January 28, 2026, by voting to maintain the federal funds rate at a target range of 3.50% to 3.75%. The decision
In a stunning display of economic resilience, the United States economy has entered 2026 by shattering expectations and effectively silencing critics of a potential recession. Despite a historic 43-day federal government shutdown that delayed official reporting, a flurry of private sector data and the Atlanta Fed’s GDPNow forecast—currently
As the first month of 2026 draws to a close, a wave of optimism is sweeping through the equity markets, fueled by a rare alignment of fiscal stimulus, aggressive deregulation, and a structural shift in corporate productivity. Major financial institutions have revised their year-end targets for the S&P 500,
